Posted on 1/14/21
Provention Bio Prices $100M Public Offering of Common Stock
Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced the pricing of its previously announced underwritten public offering . . .
Posted on 1/13/21
Cerecor Closes $36.4M Public Offering of Common Stock
ROCKVILLE, Md. and CHESTERBROOK, Pa., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (Nasdaq: CERC), a biopharmaceutical company focused on becoming a leader in development and . . .
Posted on 1/12/21
STRATA Skin Sciences Announces Preliminary Fourth Quarter 2020 Financial Results
HORSHAM, Pa., Jan. 12, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) a medical technology company in dermatology and plastic surgery dedicated to developing, . . .
Posted on 1/12/21
Tonix Pharmaceuticals Holdings Corp. Prices $40M Common Stock
CHATHAM, N.J., Jan. 11, 2021 (GLOBE NEWSWIRE) -- TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP), a clinical-stage biopharmaceutical company, today announced it has entered into a securities . . .
Posted on 1/12/21
Antares Pharma Announces Full-Year 2021 Revenue Guidance of $175-200 Million
EWING, N.J., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS), a pharmaceutical technology company, today announced guidance for full-year 2021 and expects revenue . . .
Posted on 1/12/21
electroCore Provides Business Update and Select Financial Guidance
BASKING RIDGE, N.J., Jan. 11, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today provided an operating and business update as . . .
Posted on 1/12/21
Amneal to Acquire Kashiv Specialty Pharmaceuticals
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE:AMRX) and Kashiv BioSciences LLC today announced they have entered into a definitive agreement under which Amneal Pharmaceuticals LLC, a wholly-owned subsidiary of . . .
Posted on 1/12/21
Pfizer Invests $120 Million in Biotechnology Innovation Through the Pfizer Breakthrough Growth Initiative
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that, during the second half of 2020, it invested a total of $120 million in four clinical-stage biotech . . .
Posted on 1/12/21
Vedanta Biosciences Announces $25 Million Investment from Pfizer
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta Biosciences, a leading clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally defined consortia of human microbiome-derived bacteria, . . .
Posted on 1/12/21
Is Johnson & Johnson an Underdog in the Coronavirus Vaccine Race?
The past month has been critical in the quest for a COVID-19 vaccine. Pfizer and its partner BioNTech earned emergency use authorization (EUA) Dec. 11 from . . .
Posted on 1/11/21
My Best Biotech Stock for 2021
It's only been a couple of years since BridgeBio Pharma (NASDAQ:BBIO) made its stock market debut, and the company already has two new drug applications under . . .
Posted on 1/11/21
Why Pfizer Was a Surprising Loser in 2020 but Could Win Big Time in 2021
In theory, 2020 should have been a great year for Pfizer (NYSE:PFE) shareholders. The big drugmaker, along with its German partner BioNTech (NASDAQ:BNTX), became the first . . .
Posted on 1/8/21
Pfizer Stock: A Top Bet for 2021?
If you've spent any amount of time hunting for stocks to buy in 2021, Pfizer (NYSE:PFE) and its recently authorized coronavirus vaccine probably caught your attention.Pfizer . . .
Posted on 1/7/21
Cerecor Proposes Public Offering of Common Stock
ROCKVILLE, Md. and CHESTERBROOK, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (Nasdaq: CERC), a biopharmaceutical company focused on becoming a leader in development and . . .
Posted on 1/7/21
CARISMA Therapeutics Completes $47 Million Series B Funding
CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced today that it has completed its Series B equity financing providing for . . .
Posted on 1/7/21
Onconova Therapeutics Announces $8.7 Million Public Offering
NEWTOWN, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, . . .
Posted on 1/7/21
Aquestive Therapeutics Provides Business Update
WARREN, N.J., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ . . .
Posted on 1/7/21
Pacira Reports Record Revenue for 2020 of $429.6 Million
PARSIPPANY, N.J., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the leading provider of innovative non-opioid pain management options, today reported preliminary unaudited . . .
Posted on 1/7/21
Is Pfizer Stock a Buy?
Steve Jobs once told biographer Walter Isaacson, "Deciding what not to do is as important as deciding what to do." Pfizer (NYSE:PFE) has taken that message . . .
Posted on 1/6/21
AdaptHealth Corp. Public Offering of Class A Common Stock
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO), a leading provider of home medical equipment, supplies and related services in the United States, announced today the pricing . . .
Posted on 1/6/21
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
FLORHAM PARK, N.J., Jan. 06, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines . . .
Posted on 1/6/21
Strongbridge Biopharma plc Announces Preliminary Fourth Quarter and Full-Year 2020 Financial Results and Provides Corporate Update
DUBLIN, Ireland and TREVOSE, Pa., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and . . .
Posted on 1/6/21
Could Johnson & Johnson Be a Millionaire-Maker Stock?
Investors looking for low volatility and steady, reliable returns have been attracted to Johnson & Johnson (NYSE:JNJ) for decades. The company is a Dividend King, having . . .
Posted on 1/6/21
FDA Opposes Diluting Coronavirus Vaccine Doses From Moderna and Pfizer to Boost Supply
On Monday evening, Dr. Stephen M. Hahn, director of the Food and Drug Administration, and Dr. Peter Marks, the director of the FDA's Center for Biologics . . .
Posted on 1/6/21
Pfizer Launches First Major Rebranding in Over 70 Years
Pfizer (NYSE:PFE) has swallowed its little blue pill.No, we don't mean Viagra. On Tuesday, the company formally discarded its long-standing logo, replacing it with a new . . .
Philadelphia
